We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

27 hedge funds and large institutions have $2.25M invested in Perspective Therapeutics in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

4% more funds holding

Funds holding: 26 → 27 (+1)

0.07% less ownership

Funds ownership: 0.73% → 0.66% (-0.07%)

4% less capital invested

Capital invested by funds: $2.36M → $2.25M (-$103K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 6

Holders
27
Holders Change
+1
Holders Change %
+3.85%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
+$22.7K
2
CWM
Catamount Wealth Management
Connecticut
+$1.98K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$171K
2
BlackRock
BlackRock
New York
-$45.3K
3
Citadel Advisors
Citadel Advisors
Florida
-$9K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$8.76K
5
TSS
Two Sigma Securities
New York
-$6.95K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$994K -$171K -30,274 -16%
BlackRock
2
BlackRock
New York
$547K -$45.3K -8,006 -8%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$168K – – –
BCM
4
Bridgeway Capital Management
Texas
$143K – – –
Northern Trust
5
Northern Trust
Illinois
$78K – – –
California Public Employees Retirement System
6
California Public Employees Retirement System
California
$73K – – –
Bank of New York Mellon
7
Bank of New York Mellon
New York
$42K -$8.76K -1,547 -19%
CAG
8
Crestwood Advisors Group
Massachusetts
$33K – – –
VKH
9
Virtu KCG Holdings
New York
$25K +$22.7K +4,013 New
RJFSA
10
Raymond James Financial Services Advisors
Florida
$21K – – –
IFS
11
Ifrah Financial Services
Arkansas
$19K – – –
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$13K -$2.78K -491 -19%
PNC Financial Services Group
13
PNC Financial Services Group
Pennsylvania
$13K – – –
SIA
14
Starfire Investment Advisers
Michigan
$13K – – –
TA
15
TMD & Associates
Arizona
$13K – – –
TSS
16
Two Sigma Securities
New York
$12K -$6.95K -1,228 -38%
State Street
17
State Street
Massachusetts
$10K – – –
AAM
18
Auxier Asset Management
Oregon
$9K – – –
Bank of America
19
Bank of America
North Carolina
$7K -$1.7K -300 -20%
Wells Fargo
20
Wells Fargo
California
$6K – – –
IA
21
IFP Advisors
Florida
$4K – – –
SIM
22
Sonora Investment Management
Arizona
$3.13K – – –
JFA
23
JNBA Financial Advisors
Minnesota
$3K – – –
CWM
24
Catamount Wealth Management
Connecticut
$2K +$1.98K +350 New
FANJ
25
Financial Architects (New Jersey)
New Jersey
$1K – – –
1
2

CATX Hedge Fund Activity: Q2 2017 in Review

27 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q2 2017, worth a combined $2.25M — down 4.4% from $2.36M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CATX positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 6 trimmed.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $22.7K. The largest seller was Vanguard Group, cutting an estimated $171K.

  • 27 institutional investors held Perspective Therapeutics (CATX) as of Q2 2017, up from 26 in Q1 2017.
  • Funds reported $2.25M of Perspective Therapeutics stock for Q2 2017, down 4.4% quarter-over-quarter.
  • 2 funds opened new Perspective Therapeutics positions in Q2 2017 and 1 closed out, a net change of +1 holder.
  • The largest Perspective Therapeutics buyer in Q2 2017 was Virtu KCG Holdings, an estimated $22.7K added.
  • The largest Perspective Therapeutics seller in Q2 2017 was Vanguard Group, an estimated $171K sold.

Based on aggregated 13F filings for Q2 2017.